However, PERK-PeIF2α pathway was also recently identified as a driver of SG formation in cancer cells treated with specific members of the anti-mitotic microtubule destabilising Vinca alkaloids chemotherapeutic family, although with different efficiencies [36]. The gene discussed is EIF2AK3; the disease is cancer.